In vitro and ex vivo antioxidant activities of labetalol on rabbit neutrophil respiratory burst

Advances in Therapy

Volumn 21, Issue 3, 2004, Pages 178-185

  Kouoh, Ferdinand ^a,c   Gressier, Bernard ^a,b   Dine, Thierry ^a   Luyckx, Michel ^a   Brunet, Claude ^a   Ballester, Louis ^a   Cazin, Jean Claude ^a  

^a Fac of Biol/Pharmaceut Sciences   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c UNIV LILLE   (France)

Author keywords

Antioxidant; Ex vivo; In vitro; Neutrophil; Respiratory burst; Superoxide anion

Indexed keywords

ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LABETALOL; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; HUMAN CELL; HYPERTENSION; IC 50; IN VITRO STUDY; NONHUMAN; RABBIT; RESPIRATORY BURST;

EID: 5344226372     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850123     Document Type: Article

References (28)

1. Varon J, Marik PE. The diagnostic and management of hypertension crises. Chest. 2000;118:214-227.
2. Kristal B, Shurtz-Swirski R, Chezar J, et al. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patient with essential hypertension. Am J Hypertens. 1998;11:921-928.
3. Roos D. The respiratory burst of phagocytic leucocytes. Drug Invest. 1991;3:48-58.
4. Weiss SJ. Tissue destruction by neutrophils. New Engl J Med. 1989;320:365-376.
5. Niwa Y. Oxidative injury and its defense in vivo. Rinsho Byori-Japanese J Clin Pathol. 1999;47:189-209.
6. Jaboureck-Bouttier R, Gressier B, Dine T, et al. Effects of two antihypertensive agents, labetalol and metoprolol, on the production of reactive oxygen species by normal polynuclear leukocytes in vitro. Hypertens Pregnancy. 1999;18:239-247.
7. Laurent F, Benoleil AM. Oxidative metabolism of polymorphonuclear leukocytes: modulation by adhesive stimuli. J Leuk Biol. 1991;49:217-226.
8. Tscharner von V. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature. 1986;324:369-372.
9. Kessels RGC, Ross D, Verhoeven A.J. F-Met-Leu-Phe-induced activation of phospholipase D in human neutrophils. J Biol Chem. 1991;266:23152-23156.
10. Weisdorf DJ, Thayer MS. Occult intracellular calcium pools: relevance to neutrophil oxidant production. J Lab Clin Med. 1989;114:260-265.
11. Semplicini A, Pessina AC, Rossi GP, et al. Use of labetalol in the treatment of hypertension crises. G Ital Cardiol. 1982;12:355-358.
12. Morel DR, Forster A, Suter PM. Labetalol in the treatment of hypertension following coronary-artery surgery. British Journal of Anaesthesia. 1982;54:1191-1196.
13. Fagan SC, Bowes MP, Lyden PD, Zivin JA. Acute hypertension promotes hemorrhagic transformation in a rabbit embolie stroke model: effect of labetalol. Exp Neural. 1998;150:153-158.
14. Bartsch W, Sponer G, Strein K, Bohm E, Hooper RG. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigation with carvedilol, prazosin, labetalol, and guanethidine. J Cardivasc Phamacol. 1987;10:S49-S51.
15. Kouoh F, Gressier B, Luyckx M, et al. A simple method for isolating human and rabbit polymorphonuclear neutrophils (PMNs). Biol Pharm Bull. 2000;23:1382-1383.
16. Levert H, Gressier B, Brunet C, et al. Time and concentration dependent influence of dirithromycin on neutrophils oxidative burst. J Antibiot. 1999;52:127-133.
17. Cohen HJ and Chovaniec RE. Superoxide generation by digitonin stimulated guinea pig granulocytes. A basis for continuous assay for monitoring Superoxide production and for the study of the activation of generation system. J Clin Invest. 1978;61:1081-1087.
18. Aruoma O, Halliwell B, Hoey BM and Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxil radical, Superoxide anion and hypochlorous acid. Free Radical Biol Med. 1989;6:593-597.
19. Recordati G, Zorzoli F, Pontara O, Turolo L, Zanchetti A. Factors influencing acute ischaemia-induced renal hypertension in rats. J Hypertens. 2002;20:2453-2463.
20. Taddei A, Virdis L, Ghiadoni A, Magagna A and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222-2229.
21. Vaziri ND, Wang XQ, Oveisi F and Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rat. Hypertension. 2000;36:142-146.
22. Sozmen EY, Kerry Z, Uysal F, et al. Antioxidant enzyme activities and total nitite/nitate levels in the collar model. Effect of nicardipine. Clin Chem Lab Med. 2000;38:21-25.
23. Haffner SM. Clinical relevance of the oxidative stress concept. Metabolism. 2000;49:30-34.
24. Kouoh F, Gressier B, Dine T, et al. Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils - A potential antiatherosclerotic property of calcium antagonist? Cardiovasc Drug Ther. 2002;16:515-520.
25. Chin BS, Langford NJ, Nuttall SL, Gibbs CR, Blann AD, Lip GY. Antioxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure. Eur J Heart Fail. 2003;5:171-174.
26. Kano J, Allomen H, Kleimola T. Pharmacokinetics of labetalol in healthy volunteers. Int J Clin Pharmacol Ther Toxico. 1981;19:41-44.
27. Shimpo K, Fujiwara S, Katada H, Togashi H, Yokoi Y, Tanabe T. On the acute toxicity of labetalol (AH-5158), a combined alpha-and-beta-adrenoceptor- blocking agent. Hokkaido Igaku Zasshi. 1978;53:15-21.
28. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guideline subcommittee. J Hypertens. 1999;17:151-183.